SCHEMBL10152051

SCHEMBL10152051

CCN1C(=O)CCc2ccc([N+](=O)[O-])cc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 1/20 0.50
GRIN2B Q13224 1/20 0.50
ATAD2 Q6PL18 1/20 0.50
CYP1A2 P05177 2/20 0.44
PNMT P11086 4/20 0.44
ADRA2A P08913 2/20 0.44
ADRA2B P18089 1/20 0.44
ADRA2C P18825 1/20 0.44
POLB P06746 1/20 0.42
APEX1 P27695 1/20 0.42
CASP6 P55212 1/20 0.42
CTDSP1 Q9GZU7 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
ALDH1A1 P00352 5/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
ROCK1 Q13464 1/20 0.41
DRD2 P14416 2/20 0.41
DRD4 P21917 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2061996 0.92 TDP1 (0.49) GRIN1GRIN2BATAD2CYP1A2PNMT
SCHEMBL8128306 0.89 ATAD2 (0.61) GRIN1GRIN2BATAD2CYP1A2PNMT
SCHEMBL10129647 0.81 PPARG (0.48) GRIN1GRIN2BALDH1A1SMN1; SMN2MAPT
SCHEMBL2063017 0.81 CYP1A2 (0.41) GRIN1GRIN2BATAD2CYP1A2PNMT
SCHEMBL2061799 0.79 ACHE (0.41) GRIN1GRIN2BCYP1A2PNMTADRA2A
SCHEMBL2062658 0.79 ACHE (0.41) GRIN1GRIN2BCYP1A2PNMTADRA2A
SCHEMBL495889 0.79 GRIN1 (0.46) GRIN1GRIN2BPOLBAPEX1CASP6
SCHEMBL2061813 0.79 CASP6 (0.41) GRIN1GRIN2BATAD2CYP1A2PNMT
SCHEMBL4106672 0.78 GAA (0.53) GRIN1GRIN2BATAD2CYP1A2PNMT
SCHEMBL15403488 0.78 DPP7 (0.45) GRIN1GRIN2BCYP1A2PNMTADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1955697-B1 2-AMINOBENZAMIDE DERIVATIVES AS VANILLOID RECEPTOR 1 (VR1) INHIBITORS USEFUL FOR THE TREATMENT OF PAIN OR BLADDER FUNCTION DISORDER ASTELLAS PHARMA INC (JP) 2012-05-02 EP disclosed